Literature DB >> 8914836

Specificity of aspartokinase III from Escherichia coli and an examination of important catalytic residues.

Y F Keng1, R E Viola.   

Abstract

Aspartokinase III (AK III) has been purified from a plasmid-containing strain of Escherichia coli. The enzyme shows broad specificity for the phosphoryl acceptor substrate. Structural analogs of aspartic acid with a derivatized alpha-carboxyl group are accepted as alternative substrates by the enzyme. Derivatives at the alpha-amino group are also tolerated by AK III but with diminished catalytic activity. As has been previously observed with aspartokinase I (T. S. Angeles and R. E. Viola, 1992, Biochemistry 31, 799), derivatization of the beta-carboxyl group, which serves as the phosphoryl acceptor, does not prevent catalytic activity. These beta-derivatized analogs are capable of productive binding to these enzymes through a reversal of regiospecificity, making the alpha-carboxyl group available as the phosphoryl acceptor. Chemical modification and pH profile studies have identified the functional groups of cysteine and histidine as being involved in the catalytic activity of AK III.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914836     DOI: 10.1006/abbi.1996.0483

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Structural characterization of tartrate dehydrogenase: a versatile enzyme catalyzing multiple reactions.

Authors:  Radhika Malik; Ronald E Viola
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-05-15

2.  The structural basis for allosteric inhibition of a threonine-sensitive aspartokinase.

Authors:  Xuying Liu; Alexander G Pavlovsky; Ronald E Viola
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

3.  Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor 2,4-dihydroxybutyric acid.

Authors:  Thomas Walther; Christopher M Topham; Romain Irague; Clément Auriol; Audrey Baylac; Hélène Cordier; Clémentine Dressaire; Luce Lozano-Huguet; Nathalie Tarrat; Nelly Martineau; Marion Stodel; Yannick Malbert; Marc Maestracci; Robert Huet; Isabelle André; Magali Remaud-Siméon; Jean Marie François
Journal:  Nat Commun       Date:  2017-06-20       Impact factor: 14.919

4.  A generic HTS assay for kinase screening: Validation for the isolation of an engineered malate kinase.

Authors:  Romain Irague; Christopher M Topham; Nelly Martineau; Audrey Baylac; Clément Auriol; Thomas Walther; Jean-Marie François; Isabelle André; Magali Remaud-Siméon
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

5.  Using Steady-State Kinetics to Quantitate Substrate Selectivity and Specificity: A Case Study with Two Human Transaminases.

Authors:  Alessio Peracchi; Eugenia Polverini
Journal:  Molecules       Date:  2022-02-18       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.